Adma Biologics Inc 's ability to collect accounts receivable sequentially worsen to 3.75, pointing to a challenging and on top of that deteriorating business climate for the Biotechnology & Pharmaceuticals industry. Adma Biologics Inc 's Accounts Receivable average collection period in the Mar 31 2026 quarter, has increased to 97 days, from 91 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 448 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 3038, from overall ranking in the fourth quarter 2025 at 3368.

What is Receivable Turnover Ratio?
What is Adma Biologics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ADMA Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	36.67 %	216.86 %	174.58 %	264.38 %	100.34 %
Y / Y Revenue Change	-0.3 %	18.39 %	11.67 %	13.88 %	40.67 %
Receivable Turnover Ratio (TTM)	3.75	4.02	4.9	6.11	7.97
ADMA's Total Ranking	# 3038	# 3368	# 2788	# 2301	# 1699
Accounts Receivable average collection period days	97	91	74	60	46
Seq. Receivable Change	-14.24 %	15.08 %	25.47 %	10.38 %	98.83 %
Seq. Revenue Change	-18.26 %	4.14 %	10.23 %	6.25 %	-2.94 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 49
Healthcare Sector	# 449
Overall Market	# 3038

Receivable Turnover Ratio Statistics
High	Average	Low
21.9	9.28	3.68
(Dec 31 2013)		(Dec 31 2021)

ADMA Company Profile • Back to ADMA Efficiency Comparisons • Compare ADMA Receivables Turnover Ratio to its Competitors

Financial Statements
Adma Biologics Inc 's Accounts Receivable	$ 136 Millions	Visit ADMA's Balance sheet
Adma Biologics Inc 's Sales TTM	$ 508 Millions	Visit ADMA's Income Statement
Sources of ADMA's Revenues		Visit ADMA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ADMA's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ADMA's Growth Rates	ADMA's Roa	ADMA's Inventory Turnover Ratio	ADMA's Dividend Comparisons
ADMA's Profitability Ratios	ADMA's Roi	ADMA's Asset Turnover Ratio	ADMA's Dividend Growth
ADMA's Valuation Ratios	ADMA's Roe	ADMA's Financial Strength Ratios	ADMA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
International Stem Cell Corporation	10.23	$ 9.286 Millions	$ 0.908 Millions
Pavmed Inc	10.19	$ 0.107 Millions	$ 0.011 Millions
Viemed Healthcare Inc	10.16	$ 286.565 Millions	$ 28.217 Millions
Addus Homecare Corp	10.14	$ 1,447.070 Millions	$ 142.667 Millions
Utah Medical Products Inc	10.13	$ 36.745 Millions	$ 3.629 Millions
Petvivo Holdings Inc	10.10	$ 0.821 Millions	$ 0.081 Millions
Irhythm Holdings Inc	10.00	$ 787.387 Millions	$ 78.720 Millions
C4 Therapeutics Inc	9.97	$ 34.861 Millions	$ 3.496 Millions
Biodesix Inc	9.94	$ 96.096 Millions	$ 9.665 Millions
Radnet Inc	9.87	$ 2,144.442 Millions	$ 217.223 Millions
Lensar Inc	9.87	$ 57.704 Millions	$ 5.847 Millions
X4 Pharmaceuticals Inc	9.69	$ 9.014 Millions	$ 0.931 Millions
Septerna Inc	9.64	$ 72.255 Millions	$ 7.499 Millions
Encompass Health Corporation	9.63	$ 6,066.400 Millions	$ 629.625 Millions
Biolife Solutions Inc	9.51	$ 99.673 Millions	$ 10.478 Millions
Biofrontera Inc	9.49	$ 42.983 Millions	$ 4.530 Millions
United Therapeutics Corporation	9.47	$ 3,169.800 Millions	$ 334.800 Millions
Tandem Diabetes Care Inc	9.34	$ 1,023.420 Millions	$ 109.550 Millions
Sunshine Biopharma Inc	9.33	$ 35.493 Millions	$ 3.804 Millions
The Oncology Institute Inc	9.30	$ 545.764 Millions	$ 58.671 Millions
The Pennant Group Inc	9.28	$ 1,023.227 Millions	$ 110.305 Millions
Volitionrx Limited	9.23	$ 2.466 Millions	$ 0.267 Millions
Lucid Diagnostics Inc	9.11	$ 5.134 Millions	$ 0.564 Millions
Soleno Therapeutics Inc	9.09	$ 285.008 Millions	$ 31.369 Millions
Zomedica Corp	9.07	$ 34.660 Millions	$ 3.820 Millions
Dariohealth Corp	9.03	$ 20.983 Millions	$ 2.324 Millions
Harmony Biosciences Holdings inc	9.02	$ 899.247 Millions	$ 99.660 Millions
Tactile Systems Technology Inc	9.01	$ 343.414 Millions	$ 38.110 Millions
Ardent Health Inc	8.99	$ 6,428.975 Millions	$ 715.036 Millions
Sanuwave Health Inc	8.91	$ 44.328 Millions	$ 4.973 Millions

Date modified: 2026-06-22T14:32:46+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.